These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37415045)
1. Coordinated Priming of NKG2D Pathway by IL-15 Enhanced Functional Properties of Cytotoxic CD4 Wang T; Wei L; Meng S; Song W; Chen Y; Li H; Zhao Q; Jiang Z; Liu D; Ren H; Hong X Inflammation; 2023 Oct; 46(5):1587-1601. PubMed ID: 37415045 [TBL] [Abstract][Full Text] [Related]
2. Loss of CD28 within CD4 Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292 [TBL] [Abstract][Full Text] [Related]
3. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus. Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602 [TBL] [Abstract][Full Text] [Related]
4. NKG2D Yang D; Tian Z; Zhang M; Yang W; Tang J; Wu Y; Ni B Sci Rep; 2017 Apr; 7(1):1288. PubMed ID: 28455530 [TBL] [Abstract][Full Text] [Related]
5. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616 [TBL] [Abstract][Full Text] [Related]
6. Aberrant NKG2D expression with IL-17 production of CD4+ T subsets in patients with type 2 diabetes. Phoksawat W; Jumnainsong A; Leelayuwat N; Leelayuwat C Immunobiology; 2017 Oct; 222(10):944-951. PubMed ID: 27168217 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction. Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521 [TBL] [Abstract][Full Text] [Related]
8. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus. Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119 [TBL] [Abstract][Full Text] [Related]
9. CD4 Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585 [TBL] [Abstract][Full Text] [Related]
10. Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. Dai Z; Turtle CJ; Booth GC; Riddell SR; Gooley TA; Stevens AM; Spies T; Groh V J Exp Med; 2009 Apr; 206(4):793-805. PubMed ID: 19289577 [TBL] [Abstract][Full Text] [Related]
11. IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis. Broux B; Mizee MR; Vanheusden M; van der Pol S; van Horssen J; Van Wijmeersch B; Somers V; de Vries HE; Stinissen P; Hellings N J Immunol; 2015 Mar; 194(5):2099-109. PubMed ID: 25617471 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
14. Excessive IL-15 promotes cytotoxic CD4 + CD28- T cell-mediated renal injury in lupus nephritis. Zhang T; Liu X; Zhao Y; Xu X; Liu Y; Wu X Immun Ageing; 2022 Nov; 19(1):50. PubMed ID: 36320075 [TBL] [Abstract][Full Text] [Related]
15. Phenotypical changes and clinical significance of CD4 Yuan S; Zeng Y; Li J; Wang C; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Yu N; Cai X Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35732344 [TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900 [TBL] [Abstract][Full Text] [Related]
17. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus. Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P Front Immunol; 2021; 12():633658. PubMed ID: 34012432 [TBL] [Abstract][Full Text] [Related]
18. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus. Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514 [TBL] [Abstract][Full Text] [Related]
19. An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma. Garcia-Chagollan M; Jave-Suarez LF; Haramati J; Bueno-Topete MR; Aguilar-Lemarroy A; Estrada-Chavez C; Bastidas-Ramirez BE; Pereira-Suarez AL; Del Toro-Arreola S J Biomed Sci; 2015 Oct; 22():91. PubMed ID: 26486970 [TBL] [Abstract][Full Text] [Related]
20. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Kaneko H; Saito K; Hashimoto H; Yagita H; Okumura K; Azuma M Clin Exp Immunol; 1996 Nov; 106(2):218-29. PubMed ID: 8918566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]